Literature DB >> 26212043

The Risk GP Model: the standard model of prediction in medicine.

Jonathan Fuller1, Luis J Flores2.   

Abstract

With the ascent of modern epidemiology in the Twentieth Century came a new standard model of prediction in public health and clinical medicine. In this article, we describe the structure of the model. The standard model uses epidemiological measures-most commonly, risk measures-to predict outcomes (prognosis) and effect sizes (treatment) in a patient population that can then be transformed into probabilities for individual patients. In the first step, a risk measure in a study population is generalized or extrapolated to a target population. In the second step, the risk measure is particularized or transformed to yield probabilistic information relevant to a patient from the target population. Hence, we call the approach the Risk Generalization-Particularization (Risk GP) Model. There are serious problems at both stages, especially with the extent to which the required assumptions will hold and the extent to which we have evidence for the assumptions. Given that there are other models of prediction that use different assumptions, we should not inflexibly commit ourselves to one standard model. Instead, model pluralism should be standard in medical prediction.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Extrapolation; Medicine; Prediction; Probability; Risk

Mesh:

Year:  2015        PMID: 26212043     DOI: 10.1016/j.shpsc.2015.06.006

Source DB:  PubMed          Journal:  Stud Hist Philos Biol Biomed Sci        ISSN: 1369-8486


  4 in total

1.  Characterizing treatment pathways at scale using the OHDSI network.

Authors:  George Hripcsak; Patrick B Ryan; Jon D Duke; Nigam H Shah; Rae Woong Park; Vojtech Huser; Marc A Suchard; Martijn J Schuemie; Frank J DeFalco; Adler Perotte; Juan M Banda; Christian G Reich; Lisa M Schilling; Michael E Matheny; Daniella Meeker; Nicole Pratt; David Madigan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

2.  The Confounding Question of Confounding Causes in Randomized Trials.

Authors:  Jonathan Fuller
Journal:  Br J Philos Sci       Date:  2018-01-22       Impact factor: 3.978

3.  The new medical model: a renewed challenge for biomedicine.

Authors:  Jonathan Fuller
Journal:  CMAJ       Date:  2017-05-01       Impact factor: 8.262

4.  Preventive and Curative Medical Interventions.

Authors:  Jonathan Fuller
Journal:  Synthese       Date:  2022-03-01       Impact factor: 1.595

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.